Treatments for later-life depressive conditions: A meta-analytic comparison of pharmacotherapy and psychotherapy

American Journal of Psychiatry

Volumn 163, Issue 9, 2006, Pages 1493-1501

  Pinquart, Martin ^a   Duberstein, Paul R ^b   Lyness, Jeffrey M ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; 5 HYDROXYTRYPTOPHAN; ALPRAZOLAM; AMFEBUTAMONE; DIHYDROERGOCRISTINE; FLUVOXAMINE; IPRONIAZID; LEVACECARNINE; MEDIFOXAMINE; METHYLPHENIDATE; MIANSERIN; MINAPRINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NOMIFENSINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; VENLAFAXINE; VILOXAZINE;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; DYSTHYMIA; HUMAN; INTERMETHOD COMPARISON; MAJOR DEPRESSION; META ANALYSIS; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOTHERAPY; REMISSION; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33749050835     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.9.1493     Document Type: Review

References (51)

1. Gareri P, Falconi U, De Fazio P, De Sarro G: Conventional and new antidepressant drugs in the elderly. Prog Neurobiol 2000; 61:353-396
2. Hendrie HC, Callaham CM, Levitt EE: Prevalence rates of major depressive disorders: the effects of varying diagnostic criteria in an older primary care population. Am J Geriatr Psychiatry 1995; 3:119-131
3. Lyness JM, Caine ED, King DA, Cox C, Yoediono Z: Psychiatric disorders in older primary care patients. J Gen Intern Med 1999; 14:249-254
4. Beekman AT, Penninx BW, Deeg DJ, Ormel J, Bram AW, van Tilburg W: Depression and physical health in later life: results from the Longitudinal Aging Study Amsterdam. J Affect Disord 1997; 46:219-231
5. Woo J, Ho SC, Yu AL, Lau J: An estimate of long-term care needs and identification of risk factors for institutionalization among Hong Kong Chinese aged 70 years and over. J Gerontol A Biol Med Sci 2000; 55:M64-M69
6. Fröjdh K, Håkansson A, Karlsson I, Molarius A: Deceased, disabled or depressed: a population-based 6-year follow-up study of elderly people with depression. Soc Psychiatry Psychiatr Epidemiol 2003; 38:557-562
7. Henriksson MM, Marttunen MJ, Isometsa ET, Heikkinen ME: Mental disorders in elderly suicide. Int Psychogeriatr 1995; 7:275-286
8. Conwell Y, Duberstein PR, Caine ED: Risk factors for suicide in later life. Biol Psychiatry 2002; 52:193-204
9. Wagner HR, Burns BJ, Broadhead WE, Yarnall KS: Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. Psychol Med 2000; 30:1377-1390
10. Waern M, Runeson BS, Allebeck P, Beskow J, Rubenowitz E, Skoog I, Wilhelmsson K: Mental disorder in elderly suicides: a case-control study. Am J Psychiatry 2002; 159:450-455
11. NIH Consensus Development Panel on Depression in Late Life: Diagnosis and treatment of depression in late life. JAMA 1992; 268:1018-1024
12. Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF, Alexopoulos GS, Livingston M: Diagnosis and treatment of depression in late life: consensus statement update. JAMA 1997; 278:1186-1190
13. Charney DS, Reynolds CF III, Lewis L, et al: Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry 2003; 60:664-672
14. Gerson S, Belin TR, Kaufman A, Mintz J, Jarvik L: Pharmacological and psychological treatments for depressed older patients: a meta-analysis and overview of recent findings. Harv Rev Psychiatry 1999; 7:1-28
15. Klawansky S: Meta-analysis on the treatment of depression in late life, in Diagnosis and Treatment of Depression in Late Life. Edited by Schneider LS, Reynolds CF. Washington, DC, American Psychiatric Press, 1997, pp 333-352
16. Khan A, Detke M, Khan SR, Mallinckrodt C: Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis 2003; 191:211-218
17. Rokke PD, Scogin F: Depression treatment preferences in younger and older adults. J Clin Geropsychol 1995; 1:243-258
18. Laidlaw K, Thompson LW, Dick-Siskin L, Gallagher-Thompson D: Cognitive Behavior Therapy With Older People. New York, John Wiley & Sons, 2003
19. Reynolds CF III, Miller MD, Pasternak RE, Frank E, Perel JM, Cornes C, Houck PR, Mazumdar S, Dew MA, Kupfer DJ: Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry 1999; 156:202-208
20. Thompson LW, Gallagher D, Breckenridge JS: Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol 1987; 55:385-390
21. Dhooper SS, Green SM, Huff MB, Austin-Murphy J: Efficacy of a group approach to reducing depression in nursing home elderly residents. J Gerontol Soc Work 1993; 20:87-100
22. Kraaij V, Arensman E, Spinhoven P: Negative life events and depression in elderly persons: a meta-analysis. J Gerontol B Psychol Sci Soc Sci 2002; 57(1):P87-P94
23. Wei W, Sambamoorthi U, Olfson M, Walkup JT, Crystal S: Use of psychotherapy for depression in older adults. Am J Psychiatry 2005; 162:711-717
24. Agency for Health Care Policy and Research: Depression in Primary Care: Detection, Diagnosis, and Treatment: AHCPR Publication 93-0552. Rockville, Md, Agency for Healthcare Research and Quality, 1993
25. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
26. Scogin F, McElreath L: Efficacy of psychosocial treatments for geriatric depression: a quantitative review. J Consult Clin Psychol 1994; 62:69-74
27. Cuijpers P: Psychological outreach programs for the depressed elderly: a meta-analysis of effects and dropouts. Int J Geriatr Psychiatry 1998; 13:41-48
28. Khan A, Leventhal RM, Khan SR, Brown WA: Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol 2002; 22:40-45
29. Kemp BJ, Corgiat M, Gill B: Effects of brief cognitive-behavioral group psychotherapy on older persons with and without disabling illness. Behavior, Health, and Aging 1991-1992; 2:21-27
30. Small GW, Birkett M, Meyers BS, Koran LM: Impact of physical illness on quality of life and antidepressant response in geriatric major depression: Fluoxetine Collaborative Study Group. J Am Geriatr Soc 1996; 44:1220-1225
31. Oslin DW, Datto CJ, Kallan MJ, Katz IR: Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 2002; 50:823-828
32. Schweizer E, Rickels K, Hassman H, Garcia-Espana F: Buspirone and imipramine for the treatment of major depression in the elderly. J Clin Psychiatry 1998; 59:175-183
33. Guaiana G, Barbui C, Hotopf M: Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev 2003(2):CD004186
34. Engels GI, Vermey M: Efficacy of nonmedical treatments of depression in elders: a quantitative analysis. J Clin Geropsychol 1997; 3:17-35
35. Dobson KS: A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 1989; 57:414-419
36. Blazer D: Depression in Later Life. St Louis, CV Mosby, 1993
37. Entsuah A, Huang H, Thase ME: Response and remission rates in different subpopulations with major depressive disorders administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001; 62:869-877
38. Pampallona S, Bollini P, Tibaldi G, Kupelnick B: Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004; 61:714-719
39. Montgomery SA, Åsberg M: A new depression scale designed to be more sensitive to change. Br J Psychiatry 1979; 143:382-389
40. Beck AT, Steer RA: Manual of the Revised Beck Depression Inventory. San Antonio, Tex, Psychological Corp, 1979
41. Yesavage JA, Brink TL: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17:37-49
42. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Washington, DC, US Department of Health, Education, and Welfare, 1976, pp 218-222
43. Jüni P, Witschi A, Bolsch R, Egger M: The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282:1054-1060
44. Hedges LV, Vevea JL: Fixed- and random-effects models in meta-analysis. Psychol Methods 1998; 3:486-504
45. Glass GV, McGaw B, Smith ML: Meta-Analysis in Social Research. Beverly Hills, Calif, Sage Publications, 1981
46. Mullen B: Advanced Basic Meta-Analysis. Hillsdale, NJ, Lawrence Erlbaum Associates, 1989
47. Hedges LV: Distribution theory for Glass's estimator of effect size and related estimators. J Educational Statistics 1981; 6:107-128
48. Rosenthal R: Meta-Analytic Procedures for Social Research. Beverly Hills, Calif, Sage Publications, 1991
49. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York, John Wiley & Sons, 1981
50. Cohen J: A power primer. Psychol Bull 1992; 112:155-159
51. Lebowitz BD: Clinical trials in late life: new science in old paradigms. Gerontologist 2004; 44:452-458